"Nuclear Medicine/Radiopharmaceuticals Market” Report 2024 by Delvens offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Nuclear Medicine/Radiopharmaceuticals Market size is projected to reach a CAGR of 10.1% to 2028.
Get Free Sample Report: https://www.delvens.com/get-free-sample/radiopharmaceuticals-market
Radiopharmaceuticals are pharmaceutical formulations comprising radioactive isotopes that are used in diagnosis and therapeutics. They are simple and small substances that contain a radioactive substance that is used in the treatment of cancer and cardiac & neurological disorders.
Increasing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99 are some of the factors that have supported long-term expansion for Nuclear Medicine/Radiopharmaceuticals Market.
Regional Analysis
North America is expected to account for the largest share of the nuclear medicine market during the forecast period, the large share of North America can be attributed to the development of novel technologies for radioisotope production, government funding, increasing R&D expenditure and company initiatives in the region.
Recent Developments
In 2021, Bracco entered into a partnership with CardioNavix which will help improve patient access to cardiac PET imaging.
In 2019, Curium acquired MAP Medical, which will help it to increase its footprint in Europe with direct access to Nordic and Baltic countries.
Key Players of Nuclear Medicine/Radiopharmaceuticals Market
· Mallinckrodt plc.
· General Electric Co. (healthcare division)
· Medtronic, Inc.
· Bayer AG
· Cardinal Health, Inc.
· Lantheus Medical Imaging, Inc.
· IBA Group and More
Access Full Report: https://www.delvens.com/report/radiopharmaceuticals-market
Reasons to Acquire
· Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
· Gain authentic and granular data access for Nuclear Medicine/Radiopharmaceuticals Market so as to understand the trends and the factors involved behind changing market situations
· Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
· In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns
In addition to the market data for Nuclear Medicine/Radiopharmaceuticals Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.
More Related Reports:
Animal Antibiotics and Antimicrobials Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN
+44 20 3290 6466
+0120- 4903958
